Fast and simple detection of tropical diseases

June 5, 2013, Agency for Science, Technology and Research (A*STAR), Singapore
Fast and simple detection of tropical diseases
The VereChip biochip forms a central part of the VereTrop™ diagnostic kit, which requires only a single drop of blood to screen for 13 different major tropical diseases. Credit: A*STAR Singapore Immunology Network

While medical technology and healthcare standards have improved significantly over the past century, tropical diseases continue to pose a major threat to human health. At present, vaccines are unavailable for many major tropical infections such as dengue fever and hand, foot and mouth disease. Increased exploration of tropical rainforests, international air travel, tourism to tropical regions and human migration have also led to a rising incidence of tropical diseases. Accordingly, the rapid and accurate detection of such diseases is more important than ever to facilitate prompt treatment and prevent potential pandemics.

In collaboration with Veredus Laboratories Pte Ltd, a leading supplier of innovative molecular diagnostic tools, a team of researchers from the A*STAR Singapore Immunology Network (SIgN) have created the VereChip, a that can identify 13 different major tropical diseases—including dengue fever, chikungunya, hand, , and malaria—from a single .

The biochip itself forms the core of the VereTrop diagnostic kit. Lisa Ng, the project's lead at SIgN, explains that the kit's high level of automation and efficiency are the reasons why VereTrop is poised to revolutionize the quality of testing for tropical infectious diseases. " often reflect common symptoms like fever and may not be accurately diagnosed at an early stage by doctors. This portable diagnostic kit allows accurate testing of multiple pathogenic targets from just one blood sample in a matter of hours—compared to days or even weeks for current methods," says Ng.

Together with Laurent Renia, an expert in the immunobiology of malaria at SIgN, the team successfully validated the kit with patient samples collected and tested in rural regions of the Thai–Myanmar border in northern Thailand. Due to its highly-automated nature, laboratory personnel can be trained to operate the VereTrop kit in just one day. "This innovation opens up new possibilities for the accurate and rapid diagnosis of important infectious diseases that remain the major causes of illness in the tropics," says François Nosten, director of the Shoklo Malaria Research Unit in Thailand and clinical expert on the team. "VereTrop's versatility and ease of use will no doubt change the approach to diagnostics at the periphery of the health care system."

The VereTrop diagnostic kit is the latest in a line of success stories borne of the relationship between Veredus Laboratories and A*STAR. "We have worked on several collaborative projects, including diagnostic technology for influenza and malaria, dating back to 2004," says Rosemary Tan, CEO of Veredus Laboratories. "VereTrop is another testament to the fruitful collaboration." The partners are now planning to register the biochip as an in vitro diagnostic product as early as next year.

Philip Lim, CEO of Exploit Technologies Pte Ltd (ETPL), the technology transfer arm of A*STAR, praises the success of the project and describes the novel biochip as the perfect example of a public–private partnership. "After a journey of more than three years, we are glad that such a compelling, technologically advanced product with global healthcare benefits is ready to be launched onto the market. The creation of the VereTrop™ kit is proof that local companies can work with A*STAR to achieve a competitive edge globally."

Explore further: Researchers develop first lab-on-chip for detection of multiple tropical infectious diseases

Related Stories

Researchers develop first lab-on-chip for detection of multiple tropical infectious diseases

April 25, 2013
The Agency for Science, Technology and Research (A*STAR) and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTrop, the first biochip in the molecular diagnostics ...

New malaria test kit gives a boost to elimination efforts worldwide

May 17, 2013
A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to ...

H5N1 bird flu diagnostic kit detects all known strains of virus with a single test

May 29, 2012
A close collaboration between scientists from the Experimental Therapeutics Centre (ETC) under the Agency for Science and Technology Research (A*STAR) and clinicians from Tan Tock Seng Hospital (TTSH) has enabled the successful ...

Dengue cases may be four times more common than known

April 7, 2013
There may be nearly four times as many people infected with the tropical disease dengue globally than was previously believed, according to a new study.

Nanomal smartphone-like malaria detection device to be field tested one year earlier than scheduled

April 26, 2013
A pioneering mobile device using cutting-edge nanotechnology to rapidly detect malaria infection and drug resistance will be ready for field testing this year, one year ahead of schedule.

First influenza vaccine brought to clinical testing

May 17, 2013
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza ...

Recommended for you

Researchers a step closer to understanding how deadly bird flu virus takes hold in humans

November 19, 2018
New research has taken a step towards understanding how highly pathogenic influenza viruses such as deadly bird flu infect humans.

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Antibiotic prescribing influenced by team dynamics within hospitals

November 15, 2018
Antibiotic prescribing by doctors is influenced by team dynamics and cultures within hospitals.

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.